Date amended:
External
Statements of Principles

Fracture - Benign neoplasm involving the bone Factor

Benign neoplasms of the bone include osteoma, osteoid osteoma, osteoblastoma, chondroma, osteochondroma, benign chondroblastoma, chondromyxoid fibroma, and benign giant cell tumour.

The neoplasm is usually asymptomatic until large enough to cause pain.  The condition is diagnosed using X-rays or scans.  If necessary the tumour is excised through surgery.

Last reviewed for CCPS 24 May 2007.

Preliminary questions [5638]

5749     there is some evidence that a benign neoplasm involving the bone may be a factor in the development of the condition under consideration.

5750     the veteran has had a benign neoplasm involving the bone at some time.

7608     the benign neoplasm involving the bone is an illness or injury which is identifiable. [Default true]

30219 the identified illness or injury, a benign neoplasm involving the bone, involved side and site of the body.

5759     the identified illness or injury, a benign neoplasm involving the bone, involved side and site of the body at the time of the clinical onset of the condition under consideration.

5753     the veteran has established the causal connection between the benign neoplasm involving the bone and VEA service for the clinical onset of the fracture.

5755     the veteran has established the causal connection between the benign neoplasm involving the bone and operational service for the clinical onset of the fracture.

or

5756     the veteran has established the causal connection between the benign neoplasm involving the bone and eligible service for the clinical onset of the fracture.

Clinical onset and operational service [5755]

5760     the identified illness or injury, a benign neoplasm involving side and site of the body, is causally related to operational service.

Clinical onset and eligible service [5756]

5761     the identified illness or injury, a benign neoplasm involving side and site of the body, is causally related to eligible service.